Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Today: Africa.
Press releases published on April 7, 2025
reAlpha Tech Corp. Announces Exercise of Warrants for $3.1 Million Gross Proceeds
GlobeNewswire
·
April 7, 2025
DUBLIN, Ohio, April 07, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (the “Company” or “reAlpha”), a real estate technology company developing and commercializing artificial intelligence (“AI”) technologies, today announced the entry into …
Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States
GlobeNewswire
·
April 7, 2025
EPYSQLI® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome and generalized myasthenia gravis in adults who are anti-acetylcholine …
MBX Biosciences Appoints Veteran Pharmaceutical Executive Steve Hoerter to Board of Directors
GlobeNewswire
·
April 7, 2025
CARMEL, Ind., April 07, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic …
Integral Metals Commences Phase I Exploration at KAP Project in Partnership with GeoCraft Geological Services
GlobeNewswire
·
April 7, 2025
CALGARY, Alberta, April 07, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce the engagement of GeoCraft Geological Services Corp. (“GeoCraft”) to conduct Phase 1 …
Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer
GlobeNewswire
·
April 7, 2025
SALT LAKE CITY, April 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, announced today the appointment of Brian Donnelly as chief commercial officer (CCO), effective May 1, …
CPI Aerostructures Delivers Airborne Pod Structure in Support of Northrop Grumman’s Airborne Laser Mine Detection Program for Korea
GlobeNewswire
·
April 7, 2025
EDGEWOOD, N.Y., April 07, 2025 (GLOBE NEWSWIRE) -- CPI Aerostructures, Inc. (“CPI Aero®” or the “Company”) (NYSE American: CVU) announced today that they completed production and delivery of an Airborne Laser Mine Detection System (ALMDS) pod structure for …
Verrica Pharmaceuticals Reports Strong Demand-Led Growth in YCANTH® Dispensed Applicator Units in First Quarter 2025
GlobeNewswire
·
April 7, 2025
– Company generated quarterly sequential growth with Q1 YCANTH® dispensed applicator units rising above 10,000 for the first time in a quarter – – As YCANTH distributor inventory levels have normalized, Company expects that dispensed applicator units will …
ALX Oncology Receives IND Clearance from U.S. FDA for ALX2004, a Novel EGFR-targeted Antibody-drug Conjugate
GlobeNewswire
·
April 7, 2025
ALX2004 is a potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors that was created from ALX Oncology’s proprietary linker-payload platform ALX2004, the company’s first ADC, was fully designed …
Adagene to Present at Stifel’s 2025 Virtual Targeted Oncology Forum
GlobeNewswire
·
April 7, 2025
SAN DIEGO and SUZHOU, China, April 07, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that Adagene’s Chairman, Chief Executive …
Opus Genetics Files Definitive Proxy Statement and Sends Letter to Stockholders Highlighting the Company’s Transformation and Progress
GlobeNewswire
·
April 7, 2025
Board Comments on Misguided Campaign from Mina Sooch to Replace a Majority of Opus’ Directors and Promote a Flawed Strategy Urges Stockholders to Vote on the BLUE Proxy Card FOR All Nine of the Company’s Nominees RESEARCH TRIANGLE PARK, N.C., April 07, …
Celularity Announces Publication of “Senescence, NK cells, and cancer: navigating the crossroads of aging and disease” in the April 4, 2025, Issue of Frontiers in Immunology
GlobeNewswire
·
April 7, 2025
FLORHAM PARK, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced a key publication in the April 4, 2025, issue of the prestigious peer- …
Vital Battery Metals Announces Letter of Intent to Acquire the Corvo Uranium Project in the Athabasca Basin
GlobeNewswire
·
April 7, 2025
Corvo Uranium Project Highlights More than 29 km of exploration strike length along three strong NE-SW magnetic low trends coincident with EM conductors and cross-cutting faults, providing highly prospective shallow drill targets. Uranium mineralization is …
CareCloud to Present at the LD Micro Invitational XV
GlobeNewswire
·
April 7, 2025
SOMERSET, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO), a leading provider of practice management, healthcare technology and AI-driven solutions to medical practices across the country, is pleased to …
Aspargo Labs Expands Global Leadership Team
GlobeNewswire
·
April 7, 2025
NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a specialty pharmaceutical and MedTech company focused on converting the world's most meaningful medications into liquid oral suspensions for delivery in …
Libraries Offering Brain Exercises Can Become Centers for Brain Health
GlobeNewswire
·
April 7, 2025
SAN FRANCISCO, April 07, 2025 (GLOBE NEWSWIRE) -- Libraries have long been centers for knowledge and learning, but now that libraries frequently offer free access to online apps, many libraries are taking a further step to become centers for brain health. …
Dundee Precious Metals Annual and Special Meeting of Shareholders to be held May 7, 2025
GlobeNewswire
·
April 7, 2025
TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) announces its Annual and Special Meeting of Shareholders will be held on Wednesday, May 7, 2025, at 4 PM EDT via live audio webcast. Materials for …
Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention
GlobeNewswire
·
April 7, 2025
If approved for an expanded pediatric indication, AJOVY would be the first calcitonin gene-related peptide (CGRP) antagonist for migraine prevention in adults and episodic migraine prevention in pediatric patients, addressing the high unmet need for …
Reunion Neuroscience Presents REKINDLE, a Phase 2 Clinical Trial Evaluating RE104 for the Treatment of Adjustment Disorder (AjD) in Cancer and Other Medical Illnesses at the Anxiety & Depression Association of America (ADAA) 2025 Conference
GlobeNewswire
·
April 7, 2025
-- AjD is a Mental Health Condition Triggered By a Stressful Life Event; Particularly Common in People with Serious Medical Illness -- -- AjD Represents an Area of Significant Unmet Need; No FDA-Approved Therapies Currently Available -- -- Expansion of …
Amarin Appoints JEC Capital Partners’ Michael Torok to Board of Directors
GlobeNewswire
·
April 7, 2025
DUBLIN, Ireland and BRIDGEWATER, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced the appointment of Michael Torok, Co-Founder and Managing Director of investment firm JEC Capital Partners, as a member of the …
Avicanna Announces its 5th Medical Symposium on Cannabinoid-based Medicine
GlobeNewswire
·
April 7, 2025
Bridging Science and Clinical Practice: A Gathering of Thought Leaders in Cannabinoid Medicine Live and Virtual Symposium on June 6th, 2025, at the MaRS Discovery District, Toronto TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or …